Landmark study opens door to new cancer, aging treatments

admin — Sun, 31 Aug 2008 00:00:00 -0500

(The Wistar Institute) Researchers at the Wistar Institute have deciphered the structure of the active region of telomerase, an enzyme that plays a major role in the development of nearly all human cancers. The landmark achievement opens the door to the creation of new, broadly effective cancer drugs, as well as anti-aging therapies. The study will be published online in Nature on Aug. 31.

Novel enzyme inhibitor paves way for new cancer drug

admin — Fri, 16 May 2008 00:00:00 -0500

(The Wistar Institute) Wistar Institute scientists have developed a new type of enzyme inhibitor capable of blocking a biochemical pathway that plays a key role in cancer development. Based on studies in human melanoma cells, the research paves the way for developing new ways to treat cancer by dampening overactive enzyme activity that leads to uncontrolled tumor growth. The study shows how small-molecule inhibitors can be designed to target a family of signaling proteins, called phosphatidyl-inositol-3-kinases, or PI3Ks.

wistar institute

Landmark study opens door to new cancer, aging treatments

Novel enzyme inhibitor paves way for new cancer drug